carbidopa has been researched along with Dementia Praecox in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, MH; Van Gool, AR; Zemel, D | 1 |
| Bodis-Wollner, I; Mylin, L; Thornton, J; Yahr, MD | 1 |
| Chuang, LW; Karoum, F; Liebowitz, MR; Murphy, DL; Potkin, S; Wyatt, RJ | 1 |
| Anderson, GM; Chouinard, G; Gauthier, S; Purdy, WC; Young, SN | 1 |
| Bigelow, LB; Gillin, JC; Walls, P; Wyatt, RJ | 1 |
| Ludatscher, JI | 1 |
| Friedman, JH; Max, J; Swift, R | 1 |
| Davis, BM; Davis, KL; Horvath, TB; Johns, CA; Levy, MI; Mathé, AA; Mohs, RC; Rothpearl, AB | 1 |
| Fuxe, K; Hökfelt, T; Johansson, O; Ljungdahl, A | 1 |
3 trial(s) available for carbidopa and Dementia Praecox
| Article | Year |
|---|---|
Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1979 |
Stable remission of tardive dyskinesia by L-dopa.
Topics: Adult; Aged; Antipsychotic Agents; Carbidopa; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Schizophrenia | 1989 |
Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems.
Topics: Acute Disease; Adult; Age Factors; Apomorphine; Carbidopa; Depression, Chemical; Dopamine; Humans; Levodopa; Male; Prolactin; Research Design; Schizophrenia; Schizophrenic Psychology; Sodium Chloride | 1985 |
6 other study(ies) available for carbidopa and Dementia Praecox
| Article | Year |
|---|---|
Clinical aspects of comorbid schizophrenia and idiopathic Parkinson's disease.
Topics: Antiparkinson Agents; Antipsychotic Agents; Brain; Carbidopa; Catechols; Clozapine; Diagnosis, Differential; Fluphenazine; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2014 |
Dopaminergic deficiency and delayed visual evoked potentials in humans.
Topics: Adult; Antipsychotic Agents; Carbidopa; Dopamine; Drug Therapy, Combination; Evoked Potentials, Visual; Humans; Levodopa; Middle Aged; Parkinson Disease; Phenothiazines; Schizophrenia | 1982 |
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
Topics: Carbidopa; Chronic Disease; Clorgyline; Depressive Disorder; Female; Humans; Male; Pargyline; Phenethylamines; Phenylacetates; Phenylalanine; Schizophrenia; Schizophrenia, Paranoid | 1984 |
The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.
Topics: 5-Hydroxytryptophan; Adult; Benserazide; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Humans; Hydrazines; Middle Aged; Parkinson Disease; Schizophrenia; Tryptophan | 1982 |
Idiopathic Parkinson's disease in a chronic schizophrenic patient: long-term treatment with clozapine and L-dopa.
Topics: Adult; Carbidopa; Clozapine; Dibenzazepines; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Schizophrenia | 1987 |
Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia.
Topics: Animals; Carbidopa; Dihydroxyphenylalanine; Disulfides; Dopamine; Dopamine beta-Hydroxylase; Humans; Imidazoles; Limbic System; Male; Microscopy, Fluorescence; Rats; Receptors, Drug; Reserpine; Schizophrenia | 1974 |